FNY Investment Advisers’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

FNY Investment Advisers’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23	Closed	-$3K	–	1246
2025 Q1	$3K	Buy	+23	New	+$2.87K	﹤0.01%	633

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.16B AUM 18.64% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FNY Investment Advisers's ITCI Position: Q4 2018 in Review

FNY Investment Advisers sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2018, closing a stake of 500 shares — an estimated $8.07K sold.

FNY Investment Advisers first reported a position in ITCI in Q2 2018 and held it in 2 quarters. The position peaked at $10K in Q3 2018. 127 funds tracked by Wall St. Rank hold ITCI as of Q4 2018.

FNY Investment Advisers reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2018 after selling out during the quarter.
FNY Investment Advisers sold 500 Intra-Cellular Therapies Inc. shares in Q4 2018, an estimated $8.07K.
FNY Investment Advisers first reported a position in Intra-Cellular Therapies Inc. in Q2 2018 and held it in 2 quarters.
FNY Investment Advisers's Intra-Cellular Therapies Inc. position peaked at $10K in Q3 2018.
127 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2018.

Based on FNY Investment Advisers's 13F filing for Q4 2018, filed 22 Jan 2019.